Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Teriflunomide for treatment of multiple sclerosis.]
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in taiwan.
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis.
Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis.
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Impaired Carotid Baroreflex Control of Arterial Blood Pressure in Multiple Sclerosis.
Uric acid: a potential biomarker of multiple sclerosis and of its disability.
Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis?
Medications Are Associated with Falls in People with Multiple Sclerosis: A Prospective Cohort Study.
Effects of beta 2 adrenergic agonists on axonal injury and mitochondrial metabolism in experimental autoimmune encephalomyelitis rats.
Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil.
B Cells Fuel Inflammation in Multiple Sclerosis.
Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases.
Catatonia and klüver-bucy syndrome in a patient with acute disseminated encephalomyelitis.
Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.
Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.
Expression of a Second Ecto-5'-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis.
The proline-rich region of 18.5-kDa myelin basic protein binds to the SH3-domain of Fyn tyrosine kinase with the aid of an upstream segment to form a dynamic complex in vitro.
Focal demyelinative damage and neighboring white matter integrity: an optic neuritis study.
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Modulation of C-nociceptive Activities by Inputs from Myelinated Fibers.
Pages
« first
‹ previous
…
667
668
669
670
671
672
673
674
675
…
next ›
last »